Skip to content

Clinical trials

Observational Ovarian Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Observational Country / region: Japan Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20161
20172
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan2
Daiichi Sankyo Co., Ltd.1
National Cancer Center, Japan1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms7
Fallopian Tube Neoplasms2
Uterine Cervical Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Endometrial Neoplasms1
Nasopharyngeal Carcinoma1
Recurrence1
Small Cell Lung Carcinoma1
Stomach Neoplasms1
Triple Negative Breast Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.